Cytek Biosciences Inc (NQ: CTKB )
8.800 -0.550 (-5.88%) Streaming Delayed Price Updated: 4:00 PM EDT, Mar 22, 2023 Add to My Watchlist
All News about Cytek Biosciences Inc
Cytek Biosciences Earnings Perspective: Return On Capital Employed
December 15, 2022
Cytek Biosciences to Participate in Upcoming Investor Conferences
February 06, 2023
Cytek Biosciences Reports Third Quarter 2022 Financial Results
November 09, 2022
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022
Piper Sandler Maintains Overweight Rating for Cytek Biosciences: Here's What You Need To Know
August 18, 2022
Piper Sandler has decided to maintain its Overweight rating of Cytek Biosciences (NASDAQ:CTKB) and raise its price target from $12.00 to $16.00. Shares of Cytek Biosciences are trading down 0.21%...
74 Biggest Movers From Yesterday
June 03, 2022
Goldman Sachs has decided to maintain its Buy rating of Cytek Biosciences (NASDAQ:CTKB) and lower its price target from $14.00 to $12.00. Shares of Cytek Biosciences are trading up 10.93% over the last...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following